News

Data presented at EuroPCR 2022 reinforce the impact of Abbott's minimally invasive heart devices on patient outcomes and quality of life

Findings Hold Promise for Female Patients with Calcified Coronary Artery Disease Who Previously Suffered Worse Safety Outcomes than Male Patients Undergoing Atherectomy

Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options

Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels

Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique

Custom stent was designed and developed by Gareth Morgan, MD, interventional cardiologist at Children’s Hospital Colorado, in conjunction with NuMed for Children, and implanted in father of two

100% clinical success rate: zero complications linked to robot up to 30 days post-procedure

Medtronic adds to SPYRAL HTN Global Clinical Program with late breaking clinical data for SPYRAL HTN-ON MED and GSR-DEFINE

Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice...

EchoNavigator 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transseptal puncture guidance during minimally-invasive procedures